STRYKER CORP (SYK)
Surgical & Medical Instruments & Apparatus · Surgical & Medical Instruments & Apparatus · NYSE
$331.37
-0.09%
Investingg Score
53.4 / 100
Hold
Business overview
- Gross margin is 64%
- Operating margin is 19.5%
- Free cash flow margin is 17.1%
These margin figures reflect a stable core business model that retains a solid portion of revenue as profit and cash flow.
Financial health
- Balance sheet pillar score is 53
- Market capitalization is reported as 0
- Free cash flow margin is 17.1%
Together, these metrics indicate moderate financial positioning, though complete market value data is unavailable.
- Gross Margin
- 64.0%
- Operating Margin
- 19.5%
- Current Ratio
- 1.9x
- Debt / Equity
- 0.66
- Free Cash Flow (TTM)
- $4.3B
- Interest Coverage
- 8x
Valuation
- EV to EBITDA ratio is 1.69
- Price-to-earnings ratio is Data unavailable.
- P/S ratio is 0
The low enterprise value to EBITDA multiple suggests an inexpensive valuation level based on available earnings multiples, though some valuation data points are missing.
- P/E (TTM)
- Data unavailable
- Forward P/E
- Data unavailable
- Price / Sales
- 0.0x
- EV / EBITDA
- 1.7x
- FCF Yield
- Data unavailable
Key risks
- Technical trend is sideways with an RSI of 36.31, indicating weak short-term momentum.
- Market capitalization is reported as 0, reflecting missing valuation context.
- Certain valuation metrics such as P/E and FCF yield are unavailable, creating uncertainty around pricing.
Market cap $0 · data as of 2026-08-18
Get the full interactive report
Technicals, earnings history, news, bull/base/bear scenarios, Ask the Stock, and more — free to start.
Analyze SYK with Investingg AINot investment advice. Investingg AI summarizes public data and AI-generated analysis for informational purposes only.